Showing results (291-300 of 367) with videos related to
Sort By:
Pageof 37
Reumatismo|March 19, 2005
[Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients]A Ghirardello, S Zampieri, L Iaccarino, et al.The American Journal of Pediatric Hematology/Oncology|January 1, 1990
Intestinal obstruction at the onset of acute lymphoblastic leukemia in a childG Digilio, G Multari, B Werner, et al.Chemotherapy|April 16, 2004
Determination of the pharmacodynamic profile of daptomycin against Streptococcus pneumoniae isolates with varying susceptibility to penicillin in a murine thigh infection modelPrachi K Dandekar, Pamela R Tessier, Peter Williams, et al.International Journal of Antimicrobial Agents|May 4, 2004
Efficacy of clarithromycin against Streptococcus pneumoniae expressing mef(A)-mediated resistanceDana Maglio, Blair Capitano, Mary Anne Banevicius, et al.The British Journal of Dermatology|September 1, 1992
Family history, smoking habits, alcohol consumption and risk of psoriasisL Naldi, F Parazzini, A Brevi, et al.European Journal of Pediatrics|July 1, 1992
The hepatic malignant mesenchymoma: a case reportM C Tozzi, L Tarani, R Di Nardo, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|November 1, 1994
Prospective sonographic and arthroscopic evaluation of proliferative knee joint synovitisL Rubaltelli, U Fiocco, L Cozzi, et al.Antimicrobial Agents and Chemotherapy|April 19, 2000
Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: implications for breakpoint determinationsD P Nicolau, C O Onyeji, M Zhong, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 1, 1996
Serum bactericidal activity of ceftizoxime and ceftriaxone against pathogens associated with community-acquired and nosocomial pneumoniasP P Belliveau, C D Freeman, D P Nicolau, et al.International Journal of Antimicrobial Agents|May 17, 2005
Assessment of the efficacy of telithromycin simulating human exposures against S. pneumoniae with ribosomal mutations in a murine pneumonia modelPrachi K Dandekar, Peter Williams, Pamela R Tessier, et al.Pageof 37